PURPOSE: We hypothesized that a routine one-stage exchange for treatment of chronically infected total hip replacement (THR) will lead to (1) a higher rate of infection recurrence and (2) a poorer hip outcome than the published rates after two-stage exchange. METHODS: Sixty-five cases have been treated consecutively with one-stage exchange. All patients have been followed for a period of three to six years or until death or infection recurrence. RESULTS: The five-year rate for infection recurrence was 16%. The five-year survival rate for recurrence of the index infection was 8%. Forty-two percent of the hips had a good or excellent PMA score, and 46% a good or excellent OH score. CONCLUSIONS: Routine one-stage exchange was not associated with a higher recurrence rate and a poorer hip function than previously published series of two-stage exchange. Therefore, there is little support to choose two-stage exchange as the routine treatment for management of chronically infected THR.
PURPOSE: We hypothesized that a routine one-stage exchange for treatment of chronically infected total hip replacement (THR) will lead to (1) a higher rate of infection recurrence and (2) a poorer hip outcome than the published rates after two-stage exchange. METHODS: Sixty-five cases have been treated consecutively with one-stage exchange. All patients have been followed for a period of three to six years or until death or infection recurrence. RESULTS: The five-year rate for infection recurrence was 16%. The five-year survival rate for recurrence of the index infection was 8%. Forty-two percent of the hips had a good or excellent PMA score, and 46% a good or excellent OH score. CONCLUSIONS: Routine one-stage exchange was not associated with a higher recurrence rate and a poorer hip function than previously published series of two-stage exchange. Therefore, there is little support to choose two-stage exchange as the routine treatment for management of chronically infected THR.
Authors: Matthias D Wimmer; Thomas M Randau; Sabine Petersdorf; Geert I Pagenstert; Markus Weißkopf; Dieter C Wirtz; Sascha Gravius Journal: Int Orthop Date: 2013-07-13 Impact factor: 3.075
Authors: Christopher F Wolf; Ning Yan Gu; Jason N Doctor; Paul A Manner; Seth S Leopold Journal: J Bone Joint Surg Am Date: 2011-04-06 Impact factor: 5.284
Authors: Jeong Joon Yoo; Young Sam Kwon; Kyung-Hoi Koo; Kang Sup Yoon; Young-Min Kim; Hee Joong Kim Journal: Int Orthop Date: 2008-08-13 Impact factor: 3.075
Authors: D A George; N Logoluso; G Castellini; S Gianola; S Scarponi; F S Haddad; L Drago; C L Romano Journal: BMC Infect Dis Date: 2016-10-10 Impact factor: 3.090
Authors: Jesse W P Kuiper; Christine M E Rustenburg; Jore H Willems; Steven J Verberne; Edgar J G Peters; Rachid Saouti Journal: J Bone Jt Infect Date: 2018-07-06